Retinoids as Ig Isotype-Switch Modulators 1996

Tokuyama, and Tokuyama
Department of Nuclear Medicine, Faculty of Medicine, Kanazawa University, Takaramachi, Kanazawa, Ishikawa-ken, 920, Japan

The role of retinoids was analyzed in directing isotype switching to IgA and IgG1 (IgE) by LPS-stimulated murine μ(+)B-cells in the presence of two Th2-type cytokines, IL-4 and IL-5. All trans retinoic acid (RA) enhanced the production of IgA at high concentrations (10-100 nM) in the presence of IL-5. Addition of IL-4 to the system modulated the IgA response in a dose-dependent manner. Namely, IL-4 inhibited the response at concentrations higher than 250 usolidusml, but showed slight enhancement at lower concentrations (130 usolidusml). IL-4 alone, which is considered to be an IgE isotype-switch inducer, strongly enhanced the IgG1 and IgE responses. Addition of IL-5 to the system showed a synergistic effect which could be attenuated by addition of low concentrations of RA (about 1 nM). Thus, the presence of switch modulators such as IL-4 and IL-5, their concentration ratios, and concentrations of retinoids are crucial factors in initiating and directing isotype switching to IgA and IgG1 (IgE).

UI MeSH Term Description Entries

Related Publications

Tokuyama, and Tokuyama
January 1987, Advances in experimental medicine and biology,
Tokuyama, and Tokuyama
January 2017, Journal of immunology (Baltimore, Md. : 1950),
Tokuyama, and Tokuyama
August 1992, Journal of immunology (Baltimore, Md. : 1950),
Tokuyama, and Tokuyama
June 1991, Seminars in cancer biology,
Tokuyama, and Tokuyama
March 1984, Journal of immunological methods,
Tokuyama, and Tokuyama
May 1996, International immunology,
Tokuyama, and Tokuyama
June 2011, Autoimmunity,
Tokuyama, and Tokuyama
January 1988, Monographs in allergy,
Copied contents to your clipboard!